Ferroptosis in cancer and cancer immunotherapy
Ферроптоз при раке и иммунотерапии рака
2022-02-01
SCID: 54.1/wefwjavm
Discuss with AI
Cancer immunotherapyFerroptosisFerroptosis metabolic regulationLipid peroxidationTumor drug resistance
Figures from the paper
Abstract (AI)
The hallmark of tumorigenesis is the successful circumvention of cell death regulation for achieving unlimited replication and immortality. Ferroptosis is a newly identified type of cell death dependent on lipid peroxidation which differs from classical programmed cell death in terms of morphology, physiology and biochemistry. The broad spectrum of injury and tumor tolerance are the main reasons for radiotherapy and chemotherapy failure. The effective rate of tumor immunotherapy as a new treatment method is less than 30%. Ferroptosis can be seen in radiotherapy, chemotherapy, and tumor immunotherapy; therefore, ferroptosis activation may be a potential strategy to overcome the drug resistance mechanism of traditional cancer treatments. In this review, the characteristics and causes of cell death by lipid peroxidation in ferroptosis are briefly described. In addition, the three metabolic regulations of ferroptosis and its crosstalk with classical signaling pathways are summarized. Collectively, these findings suggest the vital role of ferroptosis in immunotherapy based on the interaction of ferroptosis with tumor immunotherapy, chemotherapy and radiotherapy, thus, indicating the remarkable potential of ferroptosis in cancer treatment.
Key Findings
1
Activating ferroptosis may help overcome drug-resistance mechanisms that contribute to the failure of conventional cancer treatments.
2
Ferroptosis has substantial potential in cancer treatment, particularly through interactions with tumor immunotherapy, chemotherapy, and radiotherapy.
3
Ferroptosis is a lipid-peroxidation-dependent cell death mechanism distinct from classical programmed cell death in morphology, physiology, and biochemistry.
4
Ferroptosis occurs during radiotherapy, chemotherapy, and tumor immunotherapy, linking it to multiple cancer-treatment modalities.
5
The review summarizes three metabolic regulatory mechanisms of ferroptosis and its crosstalk with classical signaling pathways.
Research Object
Ferroptosis in cancer and cancer immunotherapy
Research Subject
The characteristics, metabolic regulation, signaling crosstalk, and therapeutic role of lipid-peroxidation-dependent ferroptosis, including its potential to overcome treatment resistance and enhance cancer immunotherapy
Publication Details
Publication Date
2022-02-01
Journal
Publisher
ISSN
Cited by
707
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest